Proven results
Qelbree is proven to significantly reduce ADHD symptoms
By reducing the impact of ADHD symptoms, Qelbree can help with the everyday things that are complicated by your ADHD.
In the 6-week clinical trial, patients taking Qelbree met the goal of a significant reduction in ADHD symptom scores at the end of the study. For some patients, Qelbree reduced ADHD symptom scores as early as week 2.
In a 6-week study, Qelbree—a non-stimulant—was proven to help effectively reduce ADHD symptoms.
Rapid and extended release for full-day coverage.
Clinical Trial Results
How we ran the study:
Qelbree was studied in adults ages 18-60 who had been diagnosed with ADHD.
The study measured what kind of changes in ADHD symptoms these adults experienced over the course of the clinical trial. They measured the frequency and severity of ADHD symptoms including inattention, hyperactivity, and impulsivity.
This was done using AISRS (Adult ADHD Investigator Symptom Rating Scale). This scale is the standard tool that helps measure the severity of symptoms over time.
Qelbree showed a significant reduction in symptom scores compared to placebo
In a six-week clinical study, Qelbree was proven to reduce AISRS symptom severity scores.
Results you can feel
Treatment with Qelbree resulted in a 41% decrease in symptoms from the start of the study, versus placebo which was 32%
†In a randomized placebo-controlled flexible-dose trial with patients taking Qelbree 200-600 mg
Patients showed symptom score improvement each week of the study compared to placebo, starting at week 2
Results your doctor can see
In a clinical study, physicians reported patients taking Qelbree had a greater improvement than patients receiving placebo. This was measured by the Clinical Global Impression Severity Scale (CGI-S)—a score physicians use to rate the observed severity of ADHD.
Physicians in the clinical study reported an improvement in the Clinical Global Impression Severity (CGI-S) scale – a score physicians use to rate the observed severity of ADHD on a medicine versus no medicine – at the end of the study.
I have the attention to help make my goals
achievable
Safety profile
Qelbree is proven to be safe‡, with manageable side effects
Qelbree was proven to be a safe‡ and effective treatment for ADHD, with a low incidence of side effects in a clinical trial.
‡Important: Monitor for mood or behavior changes. Your doctor should also monitor for changes in blood pressure and heart rate.
The majority of these side effects did not cause patients to stop treatment with Qelbree.
Qelbree is not a controlled substance and has no evidence for abuse or misuse.
Sometimes patients consider a planned break or "drug holiday" from a medication due to side effects or only take it “as needed” and not consistently. This is a conversation you should always have with your doctor before considering any kind of break.
Qelbree is unlikely to have negative interactions with stimulants like methylphenidate and amphetamine.
Most Common Side Effects
Side effect
Placebo
(183 people)
Qelbree
(189 people)
Difficulty sleeping (insomnia)§
7%
23%
Headacheǁ
7%
17%
Tiredness
3%
12%
Nausea
3%
12%
Decreased appetite
3%
10%
Dry mouth
2%
10%
Sleepiness
2%
6%
Constipation
1%
6%
§Insomnia included initial, middle, and late insomnia, poor quality sleep, sleep disorder.
ǁHeadache: headache, migraine, migraine with aura, tension headache.
9.0% of participants taking Qelbree discontinued the clinical trial due to side effects vs 4.9% taking placebo.
Ready to talk to your doctor?
If you’re ready to ask about Qelbree, we’ve got your back.
